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Arrhythmogenic Substrate of Ventricular Arrhythmias at the AMC. Introduction: Catheter
ablation of ventricular arrhythmia (VA) at the fibrous aortic mitral continuity (AMC) has been described,
yet the nature of the arrhythmogenic substrate remains unknown.
Methods: Procedural records of 528 consecutive patients undergoing ablation of VA at Mayo Clinic,
Rochester, MN, were reviewed. The electrocardiographic and electrophysiologic characteristics of patients
with successful ablation at the AMC were analyzed to characterize the underlying arrhythmogenic sub-
strate.
Results: Of the 21 patients (mean age 53.2 ± 13.4 years, 47.6% male) who underwent ablation of
VA at the AMC with acute success, prepotentials (PPs) were found at the ablation sites preceding the
ventricular electrogram (VEGM) during arrhythmias in 13 (61.9%) patients and during sinus rhythm in 7
(53.8%) patients. VAs with PPs were associated with a significantly higher burden of premature ventricular
complexes (PVCs; 26.1 ± 10.9% vs. 14.9 ± 10.1%, P = 0.03), shorter VEGM to QRS intervals (9.0 ±
28.5 milliseconds vs. 33.1 ± 8.8 milliseconds, P = 0.03), lower pace map scores (8.7 ± 1.6 vs. 11.4 ± 0.8,
P = 0.001), and a trend toward shorter V-H intervals during VA (32.1 ± 38.6 milliseconds vs. 76.3 ± 11.1
milliseconds, P = 0.06) as compared to those without PP. A strong and positive correlation was found
between V-H interval and QRS duration during arrhythmia in those with PPs (B = 2.11, R2 = 0.97, t =
13.7, P < 0.001) but not in those without PPs.
Conclusion: Local EGM characteristics and relative activation time of the His bundle suggest the pos-
sibility of conduction tissue as the origin for VA arising from the fibrous AMC. Specific identification
and targeting of PPs when ablating VAs at this location may improve procedural success. (J Cardiovasc
Electrophysiol, Vol. 26, pp. 158-163, February 2015)
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Introduction
The aortic mitral continuity (AMC) is a fibrous structure
embedded between the aortic and mitral annuli. Although
successful ablations of arrhythmias at the AMC have been
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reported in the literature,1-12 knowledge of the clinical, elec-
trocardiographic (ECG), and electrophysiological character-
istics of idiopathic ventricular arrhythmias (VAs) arising
from this region remains limited. Furthermore, being a fi-
brous structure, the exact nature of the arrhythmogenic sub-
strate remains unclear.4,13-17 To improve our understanding
of this relatively uncommon arrhythmia, we retrospectively
reviewed and described the clinical, ECG, and electrophysio-
logical characteristics of idiopathic VAs successfully ablated
at the AMC in our institution.
Methods
Patients
This study was approved by the Institutional Review
Board of Mayo Clinic, Rochester, MN. Five hundred and
twenty-eight patients who underwent ablation of idiopathic
VA at Mayo Clinic from 2002 to 2012 were retrospectively
reviewed. All patients provided informed consent before their
procedure. Twenty-one patients with definitive ablation at the
AMC, as confirmed by fluoroscopy and intracardiac echocar-
diography as stated in the procedural reports, were identified.
All patients had either spontaneously present or inducible
VAs, which allowed detailed mapping.
Electrophysiology Study and Ablation
Antiarrhythmic drugs were withheld for at least 5 half-
lives, and amiodarone was withheld for at least 2 weeks
prior to the procedure. All procedures were performed under
conscious sedation with propofol and fentanyl. Multipolar
catheters were inserted percutaneously via the right internal
jugular and the common femoral veins and were positioned
in the right atrium, right ventricle, coronary sinus, and the
His bundle region. Bipolar electrograms (EGMs) were fil-
tered with a bandpass of 30–500 Hz and displayed on a
digital recording system (Prucka Engineering, Inc., Hous-
ton, TX, USA). VAs were induced by atrial or ventricular
burst pacing or programmed stimulation as appropriate. Iso-
proterenol or epinephrine infusion was given when needed.
The mechanisms of arrhythmias were defined based on the
methods of induction and response to pacing maneuvers.18-26
A 7.5-Fr, 3.5-mm, open- or nonirrigated tip catheter was
advanced to the left ventricle via the retrograde aortic ap-
proach or through transseptal puncture to map and ablate the
VAs. Electroanatomical mapping was performed by means
of a three-dimensional mapping system (CARTO, Biosense
Webster, Inc., Diamond Bar, CA, USA). During ablation,
the earliest local EGMs or prepotentials (PPs) were targeted
for focal VAs,26 and the critical isthmuses were targeted
for reentrant VAs.25-27 Radiofrequency energy was deliv-
ered at each site for 60–120 seconds with the power out-
put capped at 25–40 W. Catheter position was confirmed
by fluoroscopy and intracardiac echocardiography. Acute
success was defined as noninducibility by pacing maneu-
vers or infusion of adrenergic agents at the end of the
procedure.
Electrocardiography
VAs targeted during procedures were reviewed offline
with our digital recording system. Twelve-lead ECGs were
interpreted at a sweep speed of 100 mm/s and amplitude of
TABLE 1
Baseline Clinical Characteristics
Pre-Ablation Postablation P Value
Symptoms (n, %)
Chest discomfort* 9 (42.9) 1 (4.8) <0.01
Fatigue* 15 (71.4) 2 (9.5) <0.001
Palpitations* 14 (66.7) 5 (23.8) <0.01
Lightheadedness/ 12 (57.1) 9 (42.9) 0.03
presyncope*
Syncope 2 (9.5) 0 (0) 0.48
PVC burden* (%) 23.4 ± 13.1 2.2 ± 3.4 <0.001
LVEF (%) 50.8 ± 12.2 51.9 ± 12.6 0.52
LVEDD (mm) 53.5 ± 5.2 52.8 ± 5.0 0.44
*P < 0.05. LVEF = left ventricular ejection fraction; LVEDD = left ven-
tricular end-diastolic diameter; PVC = premature ventricular complex.
10 mm/mV. All ECG analyses were performed according
to standard criteria by a single cardiologist blinded to the
procedural findings.28-30
Intracardiac Electrograms
Intracardiac EGMs were reviewed on our digital record-
ing system. The V-H interval was defined as the shortest
measurable interval from the onset of surface QRS to the His
deflection during VA. Local ventricular EGM (VEGM) to
QRS interval was measured from the point of maximal de-
flection (dV/dt) of the bipolar EGM to the onset of the surface
QRS.31 PP was defined as a discrete sharp deflection ahead
of and separated from the VEGM by an isoelectric segment
of more than 5 milliseconds.32,33 When the PP was identified,
PP-QRS and PP-VEGM intervals were also assessed.
Statistical Analysis
Continuous variables were reported as mean ± standard
deviation. Categorical variables were presented in frequency
tables. Statistical comparisons were performed using a 2-
tailed Student’s t-test or Wilcoxon rank sum test for contin-
uous variables, and Pearson chi-square test or Fisher’s exact
test for categorical variables, as appropriate. Relationships
between the V-H interval and QRS duration were calculated
using a linear regression model. P values of<0.05 were con-
sidered statistically significant. All analyses were performed
using SPSS software (version 21.0, SPSS, Inc., Chicago, IL,
USA).
Results
Clinical Characteristics
Twenty-one patients who had VAs successfully ablated at
the AMC were included in this study. The mean age of the
patients was 53.2 ± 13.4 years, with 10 (47.6%) of them
male. Seven (33.3%) patients had a left ventricular ejection
fraction (LVEF) of 50% before ablation. The most com-
mon presentation was symptomatic PVCs (n = 16, 76.2%).
Other presentations included heart failure (n = 2, 9.5%),
symptomatic ventricular tachycardia (VT, n = 1, 4.8%), and
PVC-triggered ventricular fibrillation (n = 3, 14.3%). Prior to
ablation, Holter recordings and exercise testing documented
PVCs in all (100%), nonsustained VT in 9 (42.9%), and
sustained VT in 2 (9.5%) patients. At a mean follow-up
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Figure 1. (A) Intracardiac recording showing a PP, as indicated by the yellow arrow. The prepotential was noted preceding the local VEGM and surface
QRS during spontaneous ectopy, with the PP-QRS being 90 milliseconds and VEGM-QRS being 15 milliseconds. (B) A premature ventricular complex with
relatively narrow QRS was associated with negative V-H interval and distal to proximal activation sequence of the His bundle as shown by the yellow arrows.
At the ablation site, PP, which is indicated by the red arrow, was found ahead of the VEGM and the onset of the surface QRS. PP = prepotential; VEGM =
ventricular electrogram.
duration of 12.7 ± 12.8 months, PVC burden was signif-
icantly reduced from 23.4 ± 13.1% to 2.2 ± 3.4% (P <
0.001, Table 1). All symptoms except syncope improved at
follow-up (all P< 0.05, Table 1). Three patients who had ini-
tial left ventricular dysfunction demonstrated improvement
of LVEF to >50% after ablation.
Prepotentials
PPs were found at the successful ablation site in 13
(61.9%) patients (Fig. 1A). The mean PP-VEGM and the
PP-QRS intervals during VAs were 65.7 ± 34.1 milliseconds
and 73.7 ± 23.6 milliseconds, respectively. PPs were seen
ahead of VEGMs during sinus rhythm in 7 (53.8%) patients.
Patients with PPs had a significantly higher PVC burden
before ablation than those without PPs (26.1 ± 10.9% vs.
14.9 ± 10.1%, P = 0.03, Table 2). Nevertheless, there was
no significant difference in patients’ demographics, clinical
presentations, types of VAs, and echocardiographic findings
between those with and without PPs (all P > 0.05, Table 2).
Multiple VA morphologies were found in 4 patients with PPs
but none in those without PP, although the difference did not
reach statistical significance (P > 0.05, Table 2).
Electrocardiographic Characteristics
ECG characteristics of VAs with and without PPs are
presented in Table 3. A total of 25 VAs were analyzed. The
mean QRS duration of VAs was 145.2 ± 16.9 milliseconds
in those with PPs and 151.3 ± 21.3 milliseconds in those
without PP (P = 0.45). Tall R waves were observed over
TABLE 2
Comparison of Clinical and Electrophysiological Characteristics of
Patients with and without Prepotentials
With PP Without PP
N = 13 N = 8 P Value
Age (years) 50.0 ± 13.4 58.4 ± 12.4 0.17
Sex (male, %) 6 (46.2) 5 (62.5) 0.66
Symptoms (n, %)
Chest discomfort 5 (38.5) 4 (50) 0.67
Fatigue 10 (76.9) 5 (62.5) 1.00
Palpitations 9 (69.2) 5 (62.5) 1.00
Lightheadedness/
presyncope
6 (46.2) 6 (75) 0.37
Syncope 0 (0) 2 (25) 0.13
Nonsustained VT 6 (46.2) 3 (37.5) 1.00
Sustained VT 0 (0) 1 (12.5) 0.38
PVC burden (%) 26.1 ± 10.9 14.9 ± 10.1 0.03
LVEF (%) 54.8 ± 9.7 48.1 ± 17.1 0.27
LVEDD (mm) 53.2 ± 4.7 53.6 ± 5.8 0.84
LVEF <50% (n, %) 3 (37.5) 4 (30.8) 1.00
>1 VA morphology at
AMC (n, %)
4 (30.8) 0 (0) 0.13
V-H interval during VA
(milliseconds)
32.1 ± 38.6 76.3 ± 11.1 0.06
VA ablated at other
regions (n, %)
1 (7.7) 4 (50) 0.047
VEGM-QRS at AMC
(milliseconds)
9.0 ± 28.5 33.1 ± 8.8 0.03
Pace map score (n/12) 8.7 ± 1.6 11.4 ± 0.8 0.001
AMC = aortomitral continuity; LVEDD = left ventricular end-diastolic
diameter; LVEF = left ventricular ejection fraction; PP = prepotential; PVC
= premature ventricular complex; VA = ventricular arrhythmia; VEGM =
ventricular electrogram; VT = ventricular tachycardia.
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TABLE 3
Electrocardiographic Morphologies of Ventricular Arrhythmias Originating from the Aortomitral Continuity
With PP (N = 17) Without PP (N = 8)
Case 1 5 6 7 10 12 13 14 17 18 19 20 21 2 3 4 8 9 11 15 16
QRS Duration
(milliseconds)
127 172 164 127 127 140 125 139 150 147 145 120 145 152 152 157 159 142 194 137 137 144 129 165 162
Coupling Interval
(milliseconds)
507 399 562 372 375 372 537 459 525 485 502 502 550 544 549 582 557 430 725 455 602 502 419 382 597
BBB R R R L L R R R R R R L R L L L R R R R R R R R R
Axis RI RI NI NI NI RI RI NI NI NI RI NI RI RI RI RI RI RI NI NI RI NI RI RI RI
V1 R Rs rsR rSr Q R R R qR R R Qr qR rS rS rSr R R R qR R R rsR R R
V2 Rs Rs Rs RSr rS R Rs R R R Rs RS R Rs rS rS Rs Rs Rs Rs Rs R rS Rs Rs
V3 R Rs R R R R Rs R R R Rs Rs R R Rs Rs R Rs R Rs Rs R Rs Rs R
V4 R Rs R R R R Rs R R R Rs Rs Rs R R Rs R Rs R R Rs R R Rs R
V5 R Rs R R R R Rs R R R Rs Rs RS R R Rs R Rs Rs R Rs R R Rs R
V6 R Rs R R R R Rs R R R Rs R RS R R Rs R Rs Rs R Rs R R Rs R
BBB = bundle branch block; L = left; N = normal; R = right.
the inferior leads in all VAs and right axis deviation in 15
(60%) of the VAs. Left bundle branch block morphology
was seen only in VA with PP (n = 6, 35.3%) but not VA
without PP (P = 0.13). Among those VAs associated with
PP, 6 (35.3%) demonstrated precordial transition >V1, 4
(23.5%) had Q waves in V1, 3 (17.6%) had RSR’ pattern in
V1, and 5 (29.4%) had deep S waves in V2. On the other
hand, Q wave in V1 was seen only in 1 VA without PP (case
4, Table 3), while RSR’ in V1, deep S wave at V2, and
precordial transition demonstrating a rebound pattern2 was
found in another VA without PP (case 11, Table 3), although
these differences did not reach statistical significance.
Electrophysiological Characteristics
VAs were induced by atrial or ventricular burst pacing in
8 out of 21 patients and infusion of adrenergic agents in 9
out of 17 patients, while none were induced by programmed
electrical stimulation. Among the 13 patients with PPs, the
earliest VEGMs were located at the AMC in 9 (69.2%), at
the junction between the great cardiac vein and the ante-
rior interventricular vein (GCV-AIVV) in 3 (23.1%), and
near the left coronary artery in 1 (7.7%). In 2 patients who
had the earliest VEGM found at the GCV-AIVV, ablation
failed to eliminate the VAs, and thus the electrophysiologists
re-mapped the entire region and found the PPs consistently
preceding the VAs at the AMC. Ablation of the PPs then
successfully eliminated the VAs. For the other 2 patients,
the electrophysiologist found the PPs at the AMC during
initial mapping and elected to target the PPs instead of the
sites of the earliest VEGM. Among the 8 patients without
PP, the earliest VEGMs were found at the AMC in 6 (75%)
and GCV-AIVV in 2 (25%). Ablations were attempted at the
GCV-AIVV in both cases. However, due to failure of power
delivery, the electrophysiologists elected to ablate endocar-
dially at the AMC, which successfully eliminated the VAs.
The mean VEGM-QRS duration at the successful
ablation sites at the AMC was significantly shorter (9.0 ±
28.5 milliseconds vs. 33.1 ± 8.8 milliseconds, P = 0.03),
and the pace map scores were significantly lower (8.7 ± 1.6
vs. 11.4 ± 0.8, P = 0.001) in those with than without PPs
(Table 2). Ablations were associated with monomorphic VT
in 8 (61.5%) patients with PPs and 3 (37.5%) without PP (P
= 1.0), and none of them had polymorphic VT or ventricular
fibrillation during the procedure.
Figure 2. Relationship between VH interval and QRS duration of ventricu-
lar arrhythmias originating from the aortomitral continuity associated with
prepotentials.
His signal was clearly seen during VAs in 7 patients with
PPs and 4 without PPs. VAs with PPs demonstrated a trend
towards a shorter V-H interval as compared to those without
PPs (32.1 ± 38.6 milliseconds vs. 76.3 ± 11.1 milliseconds,
P = 0.06, Table 2, Fig. 1B). A strong and positive correlation
existed between the V-H interval and QRS duration of VAs
with PPs (B = 2.11, R2 = 0.97, t = 13.7, P < 0.001, Fig. 2),
but not in those without PP.
Discussion
Of the 21 patients who had successful ablation of VAs at
the AMC, PPs were found in 13 (61.9%) of them. Patients
who had PPs had a higher PVC burden, and they tended to
have multiple VA morphologies and shorter V-H intervals.
The VEGM-QRS intervals at the successful ablation sites
were significantly shorter, and the pace map scores were
significantly lower in those with PPs as compared to those
without PPs. In addition, a strong and positive correlation
existed between the V-H interval and QRS duration among
those with PPs. In the remaining 8 cases no PPs were identi-
fied at the sites of successful ablation.
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Prepotentials
PP was defined as a discrete sharp deflection that pre-
ceded and was separated from the VEGM by an isoelectric
segment.31,33 A previous study in 10 patients who had VAs
ablated at the AMC by Chen et al. found similar PPs in 4
of them, although the exact mechanism was not clarified.2 In
this study, we demonstrated a strongly positive association
between the V-H interval and the QRS duration during VA,
which suggested that these PPs were likely associated with
involvement and activation of conduction tissue.
As the His-Purkinje system is a branching structure,34 the
anterograde wavefront of VA arising from the proximal con-
duction system simultaneously activates multiple portions
of the ventricular myocardium, leading to a narrow QRS
complex, while the retrograde wavefront rapidly reaches the
His bundle, giving rise to a short V-H interval. On the con-
trary, the anterograde wavefront of VA arising from the distal
conduction system activates only a limited region of the left
ventricle, leading to a wide QRS complex, while it takes
longer for the retrograde wavefront to activate the His bundle,
giving rise to a long V-H interval. Although similar relation-
ship can also be found with VAs originating from ventricular
muscle cells at the Purkinje-myocardial interface, wherein
the passively involved conduction system gives rise to the
PPs, this is less likely given that previous anatomical studies
have failed to find any myocardium in this region.
Electrocardiographic Characteristics
Previous studies on the ECG characteristics of VAs
originating from the AMC have yielded inconsistent
results.2,3,6,7,12 Chen et al. attempted to explain these differ-
ences by dividing the AMC into anterior and mid portions.2
They have shown that all VAs originating from the anterior
AMC have a left bundle branch block pattern and precor-
dial transition  V2, whereas VAs originating from the mid
AMC have a right bundle branch block pattern, and rebound
transition pattern is commonly seen.2 However, this does not
explain the variable appearance of Q waves in V1 and S waves
in some of the precordial leads.2 In our study, we found that
the QRS morphologies appeared to be more variable in VAs
associated with PPs than those without PPs. These included
the presence of left bundle branch morphology, Q waves in
V1, deep S waves in V2, and precordial transition>V1. Fur-
thermore, multiple QRS morphologies arising from the same
arrhythmic focus were also seen in those VAs associated
with PPs. Although the exact mechanism remains unknown,
one possible explanation for the variable QRS morphologies
found in this study, as well as the previous ones, could be
due to variable involvement of and exit from the His-Purkinje
system, either actively or passively.
Possible Arrhythmogenic Substrate
Although successful ablation of arrhythmias at the AMC
has been described,1-12 the exact nature of the arrhyth-
mogenic substrate remains unknown.4,13-17 While no my-
ocardium has been found in this region, animal studies
have shown that cells with electrophysiological properties
similar to that of the atrioventricular (AV) junctional cells
are present near the mitral annulus.35,36 During embryonic
development, specialized conduction tissue encircles both
AV orifices, including the fibrous AMC.4,37 This ring of
conduction tissue matures into the left and right bundle
branches, as well as a third septal branch that normally re-
gresses at the later stage.16,34 Studies have suggested that AV
junctional tissue that fails to regress can become arrhythmo-
genic later in life.4,16,36,38 Furthermore, depending on their
connection with the atrium, ventricle, and various parts of
the normal conduction system including the AV node, bundle
branches, and fascicles, arrhythmias associated with remnant
conduction tissues at the AMC may have different ECG and
electrophysiological manifestations.4,16,35,36
To our knowledge, no anatomical study has demonstrated
the presence of ventricular muscle in the AMC. While our
findings do not refute this possibility, it is plausible that
isolated cells from the degenerated conduction system give
rise to these VAs. Another possibility is that the AMC only
acts as a vantage point for ablation of epicardial arrhythmic
foci. Unfortunately, none of these possibilities can be easily
proven in human studies.
Limitations
This study had a small sample size, and thus statistical
significance was not reached in most of the electrocardio-
graphic parameters despite an apparent difference in preva-
lence. In addition, induction and pacing maneuvers were not
performed systematically in all patients due to technical dif-
ficulties or the individual electrophysiologists’ preferences.
This led to difficulty in delineating the mechanism of VA
in 3 patients. Furthermore, the V-H interval could not be
discerned in 10 patients without PP, possibly due to the
close proximity of the His signal and the VEGM. Never-
theless, the strong and positive correlation between the V-H
intervals and the QRS duration in those with PP remained.
Lastly, there are several potential reasons for a change in
the local ventricular electrogram, which include differential
movement of the mapping catheter relevant to the fibrous
AMC, different wavefront of activation of the ventricular
myocardium during the PVC versus conducted sinus beats,
or loss of catheter contact. Multiple mechanisms of arrhyth-
mia may have been operative in these patients, including
peri-AMC myocardium or Purkinje origin that could not be
distinguished from true AMC origin despite real-time in-
tracardiac ultrasound echocardiographic evaluation. Despite
these possibilities, we have shown that the site of ablation
was verified by intracardiac echo and ablation eliminated VA
at this site, making these potential alternative explanations
unlikely.
Conclusion
We present the clinical, ECG, and electrophysiological
characteristics of a series of patients who had VAs success-
fully ablated at the AMC. In particular, PPs were targeted for
successful ablation in over half of the patients. When abla-
tion at sites with the earliest VEGM and best pace map score,
which represents the exit site, does not eliminate the arrhyth-
mia, detailed mapping to identify and target the earliest PP
may improve procedural success at this location.
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